PATENT CLAIM ANALYSIS

Application Number: 15892527
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "069100"]

Abstract:
The present application provides nerve growth factor (NGF) variants with improved in vivo stability, methods for producing and purifying NGF variants, as well as potential therapeutic applications.

Claim (Index 12):
The polypeptide of  claim 11 , wherein the first portion comprises amino acid residues from position 122 to position 241 of SEQ ID NO: 5.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.14286
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849771', '12997711', '10652927', '12618896', '13946580']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5608142326763847
- 35 USC 102 Novelty (BERT): 0.5099440400541942
- Combined Prediction Score: 0.5557272134141658
- Mean Citation Score: 219.550106
- Max Citation Score: 238.7193
- Similarity Product: 152.2604005400419

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test